This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Cintas Q4 Preview: Another EPS Beat in Store?
by Derek Lewis
The company's quarterly reports have been the definition of consistency, exceeding bottom-line expectations in 20 consecutive quarters.
Cintas (CTAS) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas' (CTAS) fiscal Q4 results are likely to reflect strength in its first aid cabinet service and uniform direct sale businesses. High cost and expenses might have dragged its performance.
Cintas (CTAS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UniFirst (UNF) Q3 Earnings Miss Estimates
by Zacks Equity Research
UniFirst (UNF) delivered earnings and revenue surprises of -8.29% and 2.20%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Cintas (CTAS) Displays Bright Prospects, Headwinds Remain
by Zacks Equity Research
Cintas (CTAS) stands to benefit from strength across its businesses, focus on operational execution and shareholder-friendly policies. Rising costs and expenses along with high tax rate ail.
Cintas (CTAS) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's How Much You'd Have If You Invested $1000 in Cintas a Decade Ago
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Cintas (CTAS) Just Reclaimed the 20-Day Moving Average
by Zacks Equity Research
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
If You Invested $1000 in Cintas a Decade Ago, This is How Much It'd Be Worth Now
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Cintas (CTAS) Displays Bright Prospects Despite Challenges
by Zacks Equity Research
Cintas (CTAS) stands to benefit from end-market strength, operational execution and shareholder-friendly policies. High costs, expenses and taxes are concerning.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cintas (CTAS) Crossed Above the 200-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 200-day simple moving average?
Cintas (CTAS) Surpasses Q3 Earnings and Sales Estimates
by Zacks Equity Research
Cintas' (CTAS) fiscal Q3 revenues increase 10.3% year over year on account of impressive performance across its segments.
Company News for Mar 24, 2022
by Zacks Equity Research
Companies in The News Are: TCEHY,GIS,CTAS,EVGO
Cintas (CTAS) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 8.91% and 2.97%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Cintas (CTAS) Ahead of Earnings?
by Zacks Equity Research
Cintas (CTAS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Cintas (CTAS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cintas (CTAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cintas (CTAS) Could Beat Earnings Estimates Again
by Zacks Equity Research
Cintas (CTAS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Earnings ESP: A Better Way to Find Earnings Surprises for Industrial Products
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Cintas (CTAS) Down 12.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Cintas (CTAS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Belden (BDC) Outperforming Other Industrial Products Stocks This Year?
by Zacks Equity Research
Here is how Belden (BDC) and Cintas (CTAS) have performed compared to their sector so far this year.
Cintas (CTAS) Beats Q2 Earnings & Sales Estimates, Raises View
by Zacks Equity Research
Cintas (CTAS) Q2 results reflect gains from healthy segmental businesses, partially offset by higher costs and expenses. The company raises earnings and revenue projections for fiscal 2022.
Cintas (CTAS) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Cintas (CTAS) delivered earnings and revenue surprises of 5.34% and 0.86%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?
Cintas (CTAS) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas (CTAS) Q2 earnings likely to reflect a healthy first-aid cabinet service, demand for personal protective products, innovation capabilities, and high freight, taxes, wages and energy costs.
Cintas (CTAS) Reports Next Week: What You Should Expect
by Zacks Equity Research
Cintas (CTAS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.